MedTrace Logo

Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs

NCT07309848 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 374

Last updated 2025-12-30

No results posted yet for this study

Summary

This study looks at patients with hip fractures who are taking direct oral anticoagulants (DOACs), a type of blood thinner. In many hospitals, surgery for these patients is delayed because of concerns about bleeding, but waiting longer can also increase risks such as complications and longer hospital stays. The purpose of this study is to find out whether operating within 24 hours is as safe as delaying surgery beyond 24 hours. Specifically, the investigators want to know if early surgery does not lead to a higher need for blood transfusions compared to delayed surgery.

Conditions

  • Blood Transfusion
  • Hip Fracture Surgeries
  • Geriatric
  • Bleeding Complications
  • Bleeding as Surgical Complication (Treatment)
  • Bleeding
  • Blood Transfusions
  • Blood Transfusion Complication
  • Direct Oral Anticoagulants (DOACs)

Sponsors & Collaborators

  • St. Antonius Hospital

    lead OTHER

Principal Investigators

  • Henk Jan Schuijt, MD, PhD · Amsterdam University Medical Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-01
Primary Completion
2027-09-01
Completion
2027-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07309848 on ClinicalTrials.gov